Health ❯ Healthcare

Cancer Research

Clinical Trials Immunotherapy Biomarkers Tumor Microenvironment Clinical Studies Tumor Biology Survival Rates Innovative Therapies Epidemiology Therapeutics

3 ARTICLES

7h ago

Engineered PRAME T Cells Produce One-Year Remission in Teen With Metastatic Kidney Cancer

Investigators say the one-year remission shows that TCR‑engineered cells targeting an intracellular antigen can clear some solid tumors, prompting a planned Phase I/II pediatric trial in 2027.

3 ARTICLES

11h ago

Cypherpunk Reports $39.4 Million Q2 Profit Driven by Zcash Revaluation

3 ARTICLES

15h ago

FDA Authorizes Intermountain to Give Investigational KRAS Drug to Pancreatic Cancer Patients

Stories older than 24h

14 ARTICLES

6d ago

International Consortium Publishes 665 Validated Patient-Derived Cancer Models

3 ARTICLES

last wk.

AI Fragmentome Blood Test Improves Detection of Liver Cancer

3 ARTICLES

2w ago

FDA Grants Priority Review to Pfizer’s Talzenna Plus Xtandi for HRR-Altered mCSPC

3 ARTICLES

3w ago

WashU Team Uses In‑Body Click Chemistry to Assemble Dual‑Target Cancer Drugs

5 ARTICLES

4w ago

FDA Approves Revtorpyk for HER2‑Low Breast Cancer but Launch and Safety Questions Loom

7 ARTICLES

last mo.

EMA Opens Rolling Review as U.S. Hospitals Start Early Access to Daraxonrasib

3 ARTICLES

last mo.

Study Finds Large Gaps in Cancer Screening for Sexual and Gender Minority Adults

5 ARTICLES

last mo.

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

3 ARTICLES

2mo ago

Daraxonrasib Doubles Survival in Phase 3 Trial for Advanced Pancreatic Cancer

5 ARTICLES

2mo ago

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

3 ARTICLES

2mo ago

FDA Approves Belzutifan With Pembrolizumab as Adjuvant Therapy for Clear Cell Kidney Cancer

3 ARTICLES

2mo ago

Penn Study Finds About 30% Lower Breast Cancer Rates Associated With GLP‑1 Use

4 ARTICLES

2mo ago

Hetairos AI Classifies 102 Brain Tumor Subtypes from Routine Slides in Minutes

Cancer Research

Engineered PRAME T Cells Produce One-Year Remission in Teen With Metastatic Kidney Cancer

Cypherpunk Reports $39.4 Million Q2 Profit Driven by Zcash Revaluation

FDA Authorizes Intermountain to Give Investigational KRAS Drug to Pancreatic Cancer Patients

International Consortium Publishes 665 Validated Patient-Derived Cancer Models

AI Fragmentome Blood Test Improves Detection of Liver Cancer

FDA Grants Priority Review to Pfizer’s Talzenna Plus Xtandi for HRR-Altered mCSPC

WashU Team Uses In‑Body Click Chemistry to Assemble Dual‑Target Cancer Drugs

FDA Approves Revtorpyk for HER2‑Low Breast Cancer but Launch and Safety Questions Loom

EMA Opens Rolling Review as U.S. Hospitals Start Early Access to Daraxonrasib

Study Finds Large Gaps in Cancer Screening for Sexual and Gender Minority Adults

Never miss stories about

Cancer Research

Low-Frequency Ultrasound Selectively Kills Oral Cancer Cells

Mumbai Deploys 24 Trained Cancer Patient Navigators Across City Wards

Engineered CAR T Cells Targeting MUC16 Control Bladder Tumors in Mice

Andy Cohen Leads Tribute After WWHL Producer Kyra Samson Dies at 28

NICE Approves Pembrolizumab with Chemoradiotherapy for Locally Advanced Cervical Cancer

Daraxonrasib Doubles Survival in Phase 3 Trial for Advanced Pancreatic Cancer

FDA Accepts Roche’s Tecentriq for Priority Review in dMMR Stage III Colon Cancer

FDA Approves Belzutifan With Pembrolizumab as Adjuvant Therapy for Clear Cell Kidney Cancer

Penn Study Finds About 30% Lower Breast Cancer Rates Associated With GLP‑1 Use

Hetairos AI Classifies 102 Brain Tumor Subtypes from Routine Slides in Minutes

Never miss stories about

Cancer Research